BioNote Inc Intrinsic Valuation and Fundamental Analysis - BioNote Inc - Alpha Spread
B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 595 KRW 0.33% Market Closed
Market Cap: 468.1B KRW
Have any thoughts about
BioNote Inc?
Write Note

Intrinsic Value

The intrinsic value of one BioNote Inc stock under the Base Case scenario is 3 526.51 KRW. Compared to the current market price of 4 595 KRW, BioNote Inc is Overvalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
3 526.51 KRW
Overvaluation 23%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
BioNote Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BioNote Inc based on its intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?
How do you feel about BioNote Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about BioNote Inc

Provide an overview of the primary business activities
of BioNote Inc.

What unique competitive advantages
does BioNote Inc hold over its rivals?

What risks and challenges
does BioNote Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for BioNote Inc.

Provide P/S
for BioNote Inc.

Provide P/E
for BioNote Inc.

Provide P/OCF
for BioNote Inc.

Provide P/FCFE
for BioNote Inc.

Provide P/B
for BioNote Inc.

Provide EV/S
for BioNote Inc.

Provide EV/GP
for BioNote Inc.

Provide EV/EBITDA
for BioNote Inc.

Provide EV/EBIT
for BioNote Inc.

Provide EV/OCF
for BioNote Inc.

Provide EV/FCFF
for BioNote Inc.

Provide EV/IC
for BioNote Inc.

Show me price targets
for BioNote Inc made by professional analysts.

What are the Revenue projections
for BioNote Inc?

How accurate were the past Revenue estimates
for BioNote Inc?

What are the Net Income projections
for BioNote Inc?

How accurate were the past Net Income estimates
for BioNote Inc?

What are the EPS projections
for BioNote Inc?

How accurate were the past EPS estimates
for BioNote Inc?

What are the EBIT projections
for BioNote Inc?

How accurate were the past EBIT estimates
for BioNote Inc?

Compare the revenue forecasts
for BioNote Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of BioNote Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of BioNote Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of BioNote Inc compared to its peers.

Compare the P/E ratios
of BioNote Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing BioNote Inc with its peers.

Analyze the financial leverage
of BioNote Inc compared to its main competitors.

Show all profitability ratios
for BioNote Inc.

Provide ROE
for BioNote Inc.

Provide ROA
for BioNote Inc.

Provide ROIC
for BioNote Inc.

Provide ROCE
for BioNote Inc.

Provide Gross Margin
for BioNote Inc.

Provide Operating Margin
for BioNote Inc.

Provide Net Margin
for BioNote Inc.

Provide FCF Margin
for BioNote Inc.

Show all solvency ratios
for BioNote Inc.

Provide D/E Ratio
for BioNote Inc.

Provide D/A Ratio
for BioNote Inc.

Provide Interest Coverage Ratio
for BioNote Inc.

Provide Altman Z-Score Ratio
for BioNote Inc.

Provide Quick Ratio
for BioNote Inc.

Provide Current Ratio
for BioNote Inc.

Provide Cash Ratio
for BioNote Inc.

What is the historical Revenue growth
over the last 5 years for BioNote Inc?

What is the historical Net Income growth
over the last 5 years for BioNote Inc?

What is the current Free Cash Flow
of BioNote Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for BioNote Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioNote Inc

Current Assets 479B
Cash & Short-Term Investments 425.3B
Receivables 23.9B
Other Current Assets 29.7B
Non-Current Assets 1.2T
Long-Term Investments 1.1T
PP&E 87.7B
Intangibles 10B
Other Non-Current Assets 1.4B
Current Liabilities 34.1B
Accounts Payable 2.3B
Accrued Liabilities 1.5B
Other Current Liabilities 30.4B
Non-Current Liabilities 29B
Long-Term Debt 3B
Other Non-Current Liabilities 26B
Efficiency

Earnings Waterfall
BioNote Inc

Revenue
94.2B KRW
Cost of Revenue
-102.8B KRW
Gross Profit
-8.6B KRW
Operating Expenses
-42.7B KRW
Operating Income
-51.3B KRW
Other Expenses
70.4B KRW
Net Income
19.2B KRW

Free Cash Flow Analysis
BioNote Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

BioNote Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Exceptional Revenue Growth Forecast
Negative Gross Profit
Positive 3-Year Average ROE
49/100
Profitability
Score

BioNote Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

BioNote Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

BioNote Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
BioNote Inc

Wall Street analysts forecast BioNote Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BioNote Inc is 5 814 KRW with a low forecast of 5 757 KRW and a high forecast of 5 985 KRW.

Lowest
Price Target
5 757 KRW
25% Upside
Average
Price Target
5 814 KRW
27% Upside
Highest
Price Target
5 985 KRW
30% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BioNote Inc?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for BioNote Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about BioNote Inc dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

Price
BioNote Inc

1M 1M
-19%
6M 6M
+0%
1Y 1Y
-8%
3Y 3Y
-57%
5Y 5Y
-57%
10Y 10Y
-57%
Annual Price Range
4 595
52w Low
3 810
52w High
6 080
Price Metrics
Average Annual Return -21.22%
Standard Deviation of Annual Returns
N/A
Max Drawdown -64%
Shares Statistics
Market Capitalization 467.4B KRW
Shares Outstanding 101 876 048
Percentage of Shares Shorted
N/A

Competitive Landscape

Profile

BioNote Inc

Country

Korea

Industry

Biotechnology

Market Cap

467.4B KRW

Dividend Yield

4.35%

Description

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Contact

GYEONGGI-DO
Hwaseong
22, Samsung 1-ro 4-gil
+82312110516
www.bionote.co.kr

IPO

2022-12-22

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one BioNote Inc stock?

The intrinsic value of one BioNote Inc stock under the Base Case scenario is 3 526.51 KRW.

Is BioNote Inc stock undervalued or overvalued?

Compared to the current market price of 4 595 KRW, BioNote Inc is Overvalued by 23%.

Back to Top